足月产前筛查联合脑胎盘比率与胎盘生长因子:一项实用性随机开放标签2期试验
该单中心随机对照试验在澳大利亚布里斯班一家三级医院纳入501名孕妇,随机分为37-38周接受脑胎盘比率联合母体胎盘生长因子筛查组或常规产科护理组。筛查阳性者建议引产。主要结局为因胎窘急诊剖宫产、严重新生儿酸中毒、低Apgar评分、死产或新生儿死亡的复合结局。结论认为该筛查未改善产时干预率或新生儿结局,但显示一定鉴别潜力,未来需优化阈值。
要点
- 足月产前筛查联合CPR与PlGF未降低复合不良结局风险。
- 筛查阳性者因胎窘手术产、胎粪污染、异常胎心及低出生体重更常见。
- 筛查组与对照组主要结局发生率分别为25.3%与22.2%,无统计学差异。
核心结论
- 引入足月产前筛查试验未改善产时干预率或新生儿结局,但显示一定鉴别潜力,未来研究应聚焦优化阈值。
研究设计与样本
- 单中心、非盲、随机对照试验,在澳大利亚布里斯班一家三级医院进行,共随机501名孕妇。
- 纳入孕妇随机接受37-38周筛查试验或常规产科护理,筛查阳性者建议引产。
主要发现
- 筛查阳性者较筛查阴性者更可能需要因胎窘手术产、出现胎粪污染羊水、病理性胎心异常及分娩低出生体重儿。
关键数值与推荐
- 主要结局为因胎窘急诊剖宫产、严重新生儿酸中毒、低Apgar评分、死产或新生儿死亡的复合结局。
- 筛查时间为37-38周,筛查阳性者建议引产。
临床怎么用
- 当前证据不支持将CPR联合PlGF作为足月产前筛查常规项目以降低不良结局。
- 筛查阳性提示需加强产时监护,但需进一步研究确定适宜阈值。
局限性
- 单中心、非盲设计,样本量501例,可能限制结果外推性。
- 筛查阳性后的引产建议可能影响结局,但原文未报告依从性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: In some women placental function may not be adequate to meet fetal growth requirements in late pregnancy or the additional demands during labor, thus predisposing these infants to intrapartum fetal compromise and subsequent serious morbidity and mortality. The objective of this study was to determine if the introduction of a prelabor screening test at term combining the cerebroplacental ratio and maternal placental growth factor level would result in a reduction in a composite of adverse outcomes. STUDY DESIGN: Single-site, nonblinded, randomized controlled trial conducted at a tertiary hospital in Brisbane, Australia. Eligible women were randomized to either receive the screening test performed between 37-38 weeks or routine obstetric care. Screen-positive women were offered induction of labor. The primary outcome was a composite of emergency cesarean delivery for nonreassuring fetal status (fetal distress) or severe neonatal acidosis or low Apgar score or stillbirth or neonatal death. RESULTS: Women were recruited and randomized (n = 501) between April 2017 and January 2019. Sixty-three of 249 subjects (25.3%) in the screened group compared to 56 of 252 (22.2%) in the control group experienced the primary outcome (relative risk = 1.14 [95% confidence interval, 0.83-1.56]; P = .418). Women who screened positive were more likely to require operative delivery for fetal distress, have meconium-stained liquor, have pathologic fetal heart rate abnormalities, and have infants with lower birthweight compared to women that screened negative. CONCLUSION: The introduction of this test did not result in improvements in intrapartum intervention rates or neonatal outcomes. However, it did show discriminatory potential, and future research should focus on refining the thresholds used.
引用
- Sherrell HC, Clifton VL, Kumar S, et al. Prelabor screening at term using the cerebroplacental ratio and placental growth factor: a pragmatic randomized open-label phase 2 trial. Am J Obstet Gynecol. 2020. PMID: 32112730. doi:10.1016/j.ajog.2020.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。